Abstract
The thioredoxin system is highly conserved system found in all living cells and comprises NADPH, thioredoxin, and thioredoxin reductase. This system plays a critical role in preserving a reduced intracellular environment, and its involvement in regulating a wide range of cellular functions makes it especially vital to cellular homeostasis. Its critical role is not limited to healthy cells, it is also involved in cancer development, and is overexpressed in many cancers. This makes the thioredoxin system a promising target for cancer drug development. As such, over the last decade, many inhibitors have been developed that target the thioredoxin system, most of which are small molecules targeting the thioredoxin reductase C-terminal redox center. A few inhibitors of thioredoxin have also been developed. We believe that more efforts should be invested in developing protein/peptide-based inhibitors against both thioredoxin reductase and/or thioredoxin.
| Original language | American English |
|---|---|
| Pages (from-to) | 10175-10184 |
| Number of pages | 10 |
| Journal | Chemistry - A European Journal |
| Volume | 26 |
| Issue number | 45 |
| DOIs | |
| State | Published - 12 Aug 2020 |
Bibliographical note
Funding Information:N.M. acknowledges the Israel Science Foundation (783/18), the German‐Israeli Foundation for Scientific Research and Development (GIF) (I‐1355‐302.5/2016), and Israel Cancer Research Fund for financial support. H.G. thanks the British Council for GROWTH Ph.D. Fellowship. We would like also thank Ricki Notis Dardashti for her input on the manuscript.
Publisher Copyright:
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Keywords
- cancer
- inhibition
- oxidative stress
- thioredoxin reductase
- thioredoxin system
